Skip to content
OpenCapital
Get started

Abbott ABT Diagnostic Products — R&D

Other segment segments

Medical Devices
$444M+10.7%
Nutritional Products
$54M+3.8%
Established Pharmaceuticals
$41M-2.4%

Other financials

Income statement

See full
Revenue$11.2B+7.8%
Gross profit$6.3B+6.5%
Operating income$1.3B-20.6%
Net income$1.1B-18.7%
EPS (diluted)$0.61-19.7%

Balance sheet

See full
Cash & equivalents$6.8B+4.2%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$154.15B-22.5%
Enterprise value$181.39B-13.1%
P/E24.6×+9.8×
P/S3.4×-1.3×

Profitability

See full
Gross margin56.3%+0.4pp
Operating margin17.1%+0.2pp
Net margin13.9%-18.0pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's diagnostic products — r&d.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's diagnostic products — R&D?
Abbott (ABT) reported diagnostic products — R&D of $155M in Q1 2026.
How has Abbott's diagnostic products — R&D changed year-over-year?
Abbott's diagnostic products — R&D increased by 2.6% year-over-year, from $151M to $155M.
What is the long-term trend for Abbott's diagnostic products — R&D?
Over 3 years (2022 to 2025), Abbott's diagnostic products — R&D has grown at a -8.2% compound annual growth rate (CAGR), from $777M to $602M.
What does diagnostic products — R&D mean?
Spending on innovation and development of new diagnostic products.
How do you interpret diagnostic products — R&D?
Higher spending signals a commitment to long-term innovation, though it may temporarily compress current operating margins.
How does diagnostic products — R&D compare across companies?
Standard R&D expense metric used across the healthcare and life sciences industry.